XACT Robotics™ Ltd. began operations in August 2013, and is located in Caesarea, Israel. The company is developing a novel platform robotic technology for needle steering in minimally invasive interventional procedures, such as biopsies and ablations.
The technology is based on a novel approach to needle steering using a 5 degrees-of-freedom robot, ongoing needle path calculation, and real-time closed-loop control. XACT is currently developing the system for use in CT-guided procedures.
To provide every physician with our CAPES promise for each procedure: